- $2.09bn
- $1.98bn
- $225.21m
U.S. STOCKS ON THE MOVE-AxoGen, Portillo, Cisco Systems
AxoGen Inc reports results for the quarter ended December 31 - Earnings Summary
AxoGen rises on quarterly profit beat
U.S. RESEARCH ROUNDUP-Abbvie, Comstock Resources, Sherwin-Williams
Brief: Axogen Announces New VP Of Operations And Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
AxoGen Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Axogen Reports Q3 2024 Financial Results And Provides BLA Update
Brief: AxoGen Q3 Revenue USD 48.6 Million Vs. IBES Estimate USD 47.1 Million
Brief: Axogen Completes Submission of Biologics License Application to US FDA for Avance Nerve Graft
U.S. RESEARCH ROUNDUP-Duolingo, Nova, Universal Health Services
Brief: AxoGen Q2 Revenue USD 47.9 Million Vs. IBES Estimate USD 43.4 Million
AxoGen Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: Axogen Initiates License Application To US FDA For Avance Nerve Graft®
AxoGen Inc reports results for the quarter ended in March - Earnings Summary
U.S. RESEARCH ROUNDUP- Paramount Global, Sprout Social, Williams-Sonoma
Brief: AxoGen Q1 Revenue USD 41.4 Million Vs. IBES Estimate USD 42 Million
AxoGen Inc expected to post a loss of 7 cents a share - Earnings Preview
Brief: Axogen Files For Mixed Shelf Of Up To $100 Mln
U.S. RESEARCH ROUNDUP-Arrivent Biopharma, Ferguson, Target